Skip to the page
Get started free

Data / Research funding / Florida / Mayo Clinic Jacksonville

Mayo Clinic Jacksonville: 128 NIH awards ($275.7M), fiscal years 2021 to 2026

Mayo Clinic Jacksonville in Jacksonville, FL is funded under 128 NIH awards ($275.7M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards like theseWatch Mayo Clinic Jacksonville
UEI
GKPBCFV1QMM3
State
Florida

Awards

128 awards in the window.

AwardAgencyInstitute or divisionFiscal yearAmount in windowStartEndPrincipal investigatorSource
Biology and pathobiology of apoE in aging and Alzheimer's diseaseNIHNational Institute on Aging2021 to 2025$32,683,845June 1, 2021May 31, 2027KANEKIYO, TAKAHISAreporter.nih.gov
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populationsNIHNational Institute on Aging2023 to 2025$25,697,045March 15, 2023February 29, 2028ERTEKIN-TANER, NILUFERreporter.nih.gov
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)NIHNational Institute of Neurological Disorders and Stroke2021 to 2025$16,136,344March 15, 2014August 31, 2026BROTT, THOMAS Greporter.nih.gov
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's diseaseNIHNational Institute on Aging2022 to 2025$12,536,106February 15, 2022November 30, 2026MURRAY, MELISSA ERINreporter.nih.gov
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)NIHNational Institute of Neurological Disorders and Stroke2024 to 2025$11,846,278September 1, 2024August 31, 2028OSKARSSON, BJORN Ereporter.nih.gov
Pathobiology of Neurodegeneration in C9ORF72 repeat expansionNIHNational Institute of Neurological Disorders and Stroke2021 to 2024$9,376,142September 30, 2014March 31, 2026PETRUCELLI, LEONARDreporter.nih.gov
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body DementiaNIHNational Institute of Neurological Disorders and Stroke2021 to 2023$8,647,151September 20, 2019June 30, 2025DICKSON, DENNIS WILLIAMreporter.nih.gov
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.NIHNational Institute on Aging2021 to 2022$6,989,910September 1, 2020August 31, 2025ERTEKIN-TANER, NILUFERreporter.nih.gov
Expanding insights into FTD disease mechanismsNIHNational Institute of Neurological Disorders and Stroke2021 to 2024$6,199,699December 1, 2016November 30, 2024PETRUCELLI, LEONARDreporter.nih.gov
Bio-RaPID: Biomarkers and Rates of Progression In Dementia.NIHNational Institute on Aging2024 to 2025$4,080,222September 15, 2024May 31, 2029DAY, GREGORY SCOTTreporter.nih.gov
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insightNIHNational Institute of Neurological Disorders and Stroke2021 to 2025$3,904,675April 15, 2021March 31, 2027VAN BLITTERSWIJK, MARKAreporter.nih.gov
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical TrialNIHNational Institute of Neurological Disorders and Stroke2021 to 2025$3,784,947September 1, 2021August 31, 2026MESCHIA, JAMES Freporter.nih.gov
Investigating the role of TMEM106b genetics and pathology in Alzheimer’s disease, LATE and FTLDNIHNational Institute of Neurological Disorders and Stroke2023 to 2025$3,221,644September 22, 2023August 31, 2028PETRUCELLI, LEONARDreporter.nih.gov
Molecular characterization of extracellular vesicles for the spread of misfolded tau proteinNIHNational Institute on Aging2021 to 2025$3,058,838May 15, 2021April 30, 2027IKEZU, TSUNEYAreporter.nih.gov
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sexNIHNational Heart, Lung, and Blood Institute2022 to 2025$2,970,040July 1, 2022June 30, 2027FAIRWEATHER, DELISAreporter.nih.gov
TREM2-mediated microglial dynamic function in Alzheimer diseaseNIHNational Institute on Aging2021 to 2024$2,968,448February 1, 2020December 31, 2025ZHAO, NAreporter.nih.gov
Novel role of urinary urate in renal cystogenesis and water regulationNIHNational Institute of Diabetes and Digestive and Kidney Diseases2025$2,967,657September 1, 2025August 31, 2029CHEBIB, FOUAD Treporter.nih.gov
Assessment of a novel tau propagation pathway from layer II medial entorhinal cortical neurons to CA1 pyramidal neurons as an early Braak stage mouse modelNIHNational Institute on Aging2021 to 2025$2,653,802July 1, 2021April 30, 2027IKEZU, TSUNEYAreporter.nih.gov
Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)NIHNational Cancer Institute2022 to 2025$2,548,753February 1, 2022January 31, 2027SHERMAN, MARK Ereporter.nih.gov
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementiasNIHNational Institute on Aging2022 to 2023$2,487,597September 15, 2022August 31, 2025ROSSOLL, WILFRIEDreporter.nih.gov
PaSAGE: PAtient Supported Approaches to Gene EditingNIHNational Human Genome Research Institute2022 to 2024$2,417,150September 23, 2022June 30, 2025ALLYSE, MEGAN A.reporter.nih.gov
C9orf72-mediated features, transcriptomic signatures, and translational studies for frontotemporal dementia and related disordersNIHNational Institute of Neurological Disorders and Stroke2022$2,351,241June 15, 2022May 31, 2025VAN BLITTERSWIJK, MARKAreporter.nih.gov
Poly(ADP-ribose) promotes the condensation and toxicity of C9orf72 arginine-rich dipeptide repeat proteinsNIHNational Institute of Neurological Disorders and Stroke2021 to 2025$2,345,590July 15, 2021June 30, 2027ZHANG, YONGJIEreporter.nih.gov
Targeting Go and Grow in GlioblastomaNIHNational Institute of Neurological Disorders and Stroke2021 to 2024$2,271,628September 1, 2020June 30, 2025ROSENFELD, STEVEN Sreporter.nih.gov
Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in ADNIHNational Institute on Aging2021 to 2022$2,260,890September 30, 2018April 30, 2024ERTEKIN-TANER, NILUFERreporter.nih.gov
Role of apoE-mediated meningeal lymphatic remodeling in the pathophysiology of Alzheimer’s diseaseNIHNational Institute on Aging2023$2,250,745September 1, 2023August 31, 2026DA MESQUITA, SANDROreporter.nih.gov
Involution-based biomarkers of breast cancer riskNIHNational Cancer Institute2021 to 2024$2,246,190September 1, 2020May 31, 2025RADISKY, DEREK Creporter.nih.gov
PRSS1 Mutation and Pancreatic Cancer TumorigenesisNIHNational Cancer Institute2021 to 2025$2,153,348September 1, 2025August 31, 2027JI, BAOANreporter.nih.gov
APOE and microglia-mediated progression in tau pathology in ADNIHNational Institute on Aging2021$2,151,974September 30, 2016August 31, 2024IKEZU, TSUNEYAreporter.nih.gov
Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALSNIHNational Institute on Aging2023 to 2025$2,130,126December 1, 2022November 30, 2027ROSSOLL, WILFRIEDreporter.nih.gov
Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular HealthNIHEunice Kennedy Shriver National Institute of Child Health & Human Development2022 to 2024$2,105,761September 1, 2021July 31, 2025SHUFELT, CHRISANDRA LEEreporter.nih.gov
Mechanisms of Hereditary PancreatitisNIHNational Institute of Diabetes and Digestive and Kidney Diseases2021 to 2025$2,080,171July 12, 2019February 28, 2028JI, BAOANreporter.nih.gov
Neuronal ABCA7 loss of function and Alzheimer’s diseaseNIHNational Institute on Aging2023$2,063,098June 1, 2023May 31, 2026KANEKIYO, TAKAHISAreporter.nih.gov
A Multi-level Approach to Connecting Individuals to Cancer Clinical ResearchNIHNational Cancer Institute2023 to 2025$2,033,939September 9, 2022August 31, 2027RAUP-KRIEGER, JANICE LEEreporter.nih.gov
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation SystemNIHNational Institute on Aging2024 to 2025$1,995,209September 1, 2023May 31, 2028TAO, CUIreporter.nih.gov
Tumor susceptibility gene 101, a new microglial therapy candidate for Alzheimer’s disease to prevent cognitive declineNIHNational Institute on Aging2023$1,994,202September 1, 2023August 31, 2026IKEZU, SEIKOreporter.nih.gov
Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical TrialNIHNational Institute on Aging2023 to 2025$1,976,864March 15, 2023February 29, 2028TOFTHAGEN, CINDYreporter.nih.gov
Impact of T cells on the CNS during aging and Alzheimer’s diseaseNIHNational Institute on Aging2021 to 2024$1,940,600August 1, 2020April 30, 2026COOK, CASEY Nreporter.nih.gov
Individualized medicine to predict and prevent chemotherapy-related heart failureNIHNational Heart, Lung, and Blood Institute2023 to 2025$1,934,221July 1, 2023November 30, 2026NORTON, NADINEreporter.nih.gov
Mechanistic insights into the link between the A152T risk variant and tauopathyNIHNational Institute on Aging2021 to 2024$1,923,008April 15, 2020March 31, 2026COOK, CASEY Nreporter.nih.gov
A phase I/II study of combined therapy with Th17-inducing dendritic cells and pembrolizumab in patients with recurrent epithelial ovarian cancerNIHNational Cancer Institute2023 to 2025$1,881,216July 1, 2023June 30, 2028KNUTSON, KEITH L.reporter.nih.gov
Distinct Pathways of VPF/VEGF ReceptorsNIHNational Heart, Lung, and Blood Institute2021 to 2025$1,833,162December 8, 2017June 30, 2028MUKHOPADHYAY, DEBABRATAreporter.nih.gov
Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cellsNIHNational Institute on Aging2022 to 2024$1,813,828June 1, 2022February 28, 2028COOK, CASEY Nreporter.nih.gov
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastomaNIHNational Institute of Neurological Disorders and Stroke2023 to 2025$1,774,749December 1, 2022November 30, 2027QUINONES-HINOJOSA, ALFREDOreporter.nih.gov
Therapeutic implication of CD38 in CLLNIHNational Cancer Institute2021 to 2023$1,773,312September 4, 2019August 31, 2025CHINI, EDUARDO Nreporter.nih.gov
Discovery of apoE4 modulators for Alzheimer’s disease therapyNIHNational Institute on Aging2022 to 2025$1,763,127September 30, 2022May 31, 2027LI, YONGHEreporter.nih.gov
A Genetically Tractable Mouse Model for PRKCI-driven Lung Squamous Cell CarcinomaNIHNational Cancer Institute2021 to 2025$1,757,751July 1, 2021June 30, 2027FIELDS, ALAN P.reporter.nih.gov
Extracellular vesicle-based senotherapeutics for aging diabetic kidneydiseaseNIHNational Institute on Aging2023 to 2025$1,725,246June 1, 2023February 29, 2028HICKSON, LATONYA Jreporter.nih.gov
Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimer’s diseaseNIHNational Institute on Aging2023 to 2025$1,632,295February 1, 2023January 31, 2028IKEZU, SEIKOreporter.nih.gov
The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)NIHNational Cancer Institute2023 to 2025$1,624,406September 16, 2022August 31, 2027ODEDINA, FOLAKEMI Treporter.nih.gov
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapyNIHNational Cancer Institute2021 to 2025$1,597,561March 1, 2021February 28, 2027RADISKY, EVETTE Sreporter.nih.gov
Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's diseaseNIHNational Institute on Aging2021 to 2024$1,565,000February 1, 2020February 28, 2026IKEZU, TSUNEYAreporter.nih.gov
Standardizing and Harmonizing Behavioral and Social Science Research Factors in Alzheimer's Disease through Ontology-Based ApproachesNIHNational Institute on Aging2024 to 2025$1,553,483September 1, 2024August 31, 2029TAO, CUIreporter.nih.gov
Elucidating the Pathomechanisms of APOE4 in Lewy Body DementiaNIHNational Institute on Aging2024 to 2025$1,538,709July 1, 2024March 31, 2029ZHAO, NAreporter.nih.gov
Mitochondrial Sirtuin 3 in Parkinson's diseaseNIHNational Institute of Neurological Disorders and Stroke2021 to 2023$1,499,835June 1, 2019May 31, 2025MCLEAN, PAMELA Jreporter.nih.gov
Disease Progression Modeling of Bladder CancerNIHNational Cancer Institute2022 to 2025$1,490,713August 1, 2022July 31, 2028GOODISON, STEVEreporter.nih.gov
APOE and microglia-mediated progression in tau pathology in ADNIHNational Institute on Aging2024 to 2025$1,448,616September 30, 2016August 31, 2026IKEZU, TSUNEYAreporter.nih.gov
Predicting Breast Cancer Risk after Benign Percutaneous BiopsyNIHNational Cancer Institute2021 to 2022$1,379,527July 5, 2018June 30, 2024SHERMAN, MARK Ereporter.nih.gov
Rational translation of gold nanoparticle mediated radiosensitization tothe clinicNIHNational Cancer Institute2021 to 2022$1,222,438January 13, 2021September 5, 2022KRISHNAN, SUNILreporter.nih.gov
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathologyNIHNational Institute of Neurological Disorders and Stroke2021$1,213,868September 25, 2017August 31, 2024RADEMAKERS, ROSAreporter.nih.gov
Exploiting new approaches for selective inhibition of trypsinsNIHNational Institute of General Medical Sciences2022 to 2025$1,179,085January 1, 2022June 30, 2026RADISKY, EVETTE Sreporter.nih.gov
Endothelial cell senescence and APOE4 in vascular cognitive impairment and dementiaNIHNational Institute on Aging2021$1,173,750March 15, 2021February 29, 2024KANEKIYO, TAKAHISAreporter.nih.gov
Tuning Mitotic Kinesins Through Motor Domain Post Translational ModificationsNIHNational Institute of General Medical Sciences2021 to 2022$1,157,394March 15, 2019January 31, 2024ROSENFELD, STEVEN Sreporter.nih.gov
Deciphering Pancreatitis Microenvironment through Intravital ImagingNIHNational Institute of Diabetes and Digestive and Kidney Diseases2024 to 2025$1,157,318April 1, 2024March 31, 2029BI, YANreporter.nih.gov
Expanding insights into FTD disease mechanismsNIHNational Institute of Neurological Disorders and Stroke2025$1,138,538December 15, 2024November 30, 2032PETRUCELLI, LEONARDreporter.nih.gov
Mayo Advancing Research Engagement in ADRD Study (MAREAS Jax)NIHNational Institute on Aging2025$1,133,766September 15, 2023August 31, 2028LACHNER, CHRISTIANreporter.nih.gov
Mayo Advancing Research Equity in ADRD Study in Jacksonville(MAREAS-Jax)NIHNational Institute on Aging2023 to 2024$1,091,112September 15, 2023August 31, 2025LACHNER, CHRISTIANreporter.nih.gov
Role of ICAM1 in development and progression of pancreatic cancerNIHNational Cancer Institute2021 to 2023$1,059,662March 1, 2019August 31, 2025STORZ, PETERreporter.nih.gov
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)NIHNational Institute of Allergy and Infectious Diseases2025$1,017,955July 10, 2024April 30, 2029BLUMENTHAL, KIMBERLY G.reporter.nih.gov
Protein Kinase C Signaling Mechanisms in CancerNIHNational Cancer Institute2021 to 2022$1,001,638April 2, 1999June 30, 2024FIELDS, ALAN P.reporter.nih.gov
Engineering selective inhibition of metalloproteinases by tissue inhibitors of metalloproteinases (R01 GM132100 RESUB - *TIMPs)NIHNational Institute of General Medical Sciences2021 to 2023$939,000April 1, 2020December 31, 2024RADISKY, EVETTE Sreporter.nih.gov
A novel microfluidic device to predict brain cancer prognosis and response to therapyNIHNational Cancer Institute2021 to 2022$937,498February 14, 2018January 31, 2024QUINONES-HINOJOSA, ALFREDOreporter.nih.gov
Targeting Signaling Between Glioblastoma and the Subventricular Zone NicheNIHNational Institute of Neurological Disorders and Stroke2024 to 2025$884,125September 1, 2024August 31, 2029GUERRERO-CAZARES, HUGOreporter.nih.gov
Role of Sirt2 in T Cell MetabolismNIHNational Cancer Institute2023 to 2025$875,694March 1, 2021February 28, 2026KIM, SUNGJUNEreporter.nih.gov
Supporting Just-in-Time Consent for Prenatal Screening in Diverse PopulationsNIHNational Human Genome Research Institute2024$812,285September 18, 2024June 30, 2028ALLYSE, MEGAN A.reporter.nih.gov
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticlesNIHNational Institute of Dental & Craniofacial Research2021 to 2022$789,419March 20, 2020September 21, 2022KRISHNAN, SUNILreporter.nih.gov
C9orf72-mediated features transcriptomic signatures and translational studies for frontotemporal dementia and related disordersNIHNational Institute of Neurological Disorders and Stroke2025$788,248June 15, 2022May 31, 2027VAN BLITTERSWIJK, MARKAreporter.nih.gov
Clinicopathologic and Neuroimaging Differences in Alzheimer's Disease VariantsNIHNational Institute on Aging2021$781,978September 1, 2017May 31, 2023MURRAY, MELISSA ERINreporter.nih.gov
Endothelial cell senescence and APOE4 in vascular cognitive impairment and dementiaNIHNational Institute on Aging2024 to 2025$774,675March 15, 2021February 28, 2026KANEKIYO, TAKAHISAreporter.nih.gov
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementiasNIHNational Institute on Aging2025$722,870September 15, 2022August 31, 2027ROSSOLL, WILFRIEDreporter.nih.gov
Extracellular vesicle RNA signaling in liver tumor microenvironmentNIHNational Cancer Institute2021 to 2022$708,828February 8, 2018January 31, 2024PATEL, TUSHARreporter.nih.gov
Protein Kinase D1 as a switch from acute to chronic pancreatitisNIHNational Institute of Diabetes and Digestive and Kidney Diseases2024 to 2025$680,776April 1, 2024March 31, 2028STORZ, PETERreporter.nih.gov
Integrated molecular epidemiologic analysis of the one-carbon metabolism pathway and risk of HCCNIHNational Cancer Institute2021 to 2024$678,224April 1, 2020March 31, 2025ANTWI, SAMUEL O.reporter.nih.gov
Osteopontin-CD44 role in the malignancy of lateral ventricle infiltrating glioblastomaNIHNational Institute of Neurological Disorders and Stroke2021 to 2023$631,800September 1, 2022August 31, 2024GUERRERO-CAZARES, HUGOreporter.nih.gov
Translation of a Clinical Molecular Diagnostic Assay for Bladder CancerNIHNational Cancer Institute2021$626,934August 1, 2017July 31, 2024GOODISON, STEVEreporter.nih.gov
Generating Synthetic Lethality in Glioblastoma with a First-In-Class Non-Muscle Myosin II InhibitorNIHNational Cancer Institute2025$607,634January 1, 2025December 31, 2029ROSENFELD, STEVEN Sreporter.nih.gov
ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's diseaseNIHNational Institute on Aging2021$606,716May 1, 2006May 31, 2023LI, YONGHEreporter.nih.gov
Tailoring Recruitment Communication using Virtual Human Technology to Increase Participation of Older Minority Adults in Clinical TrialsNIHNational Institute on Aging2023$561,112September 30, 2021August 31, 2025RAUP-KRIEGER, JANICE LEEreporter.nih.gov
Targeting Kif11 to Treat Glioblastoma Invasion and ProliferationNIHNational Institute of Neurological Disorders and Stroke2021$560,593July 1, 2017December 31, 2021ROSENFELD, STEVEN Sreporter.nih.gov
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to BedsideNIHNational Cancer Institute2021$550,967April 7, 2010December 31, 2023MUKHOPADHYAY, DEBABRATAreporter.nih.gov
Role of CD38 in NAD metabolism: from the basic biology of aging to translationNIHNational Institute on Aging2021 to 2022$532,144June 1, 2018February 28, 2025CHINI, EDUARDO Nreporter.nih.gov
Rapidly Progressive Dementia: Moving Beyond CJDNIHNational Institute on Aging2021 to 2023$498,588August 1, 2019January 31, 2024DAY, GREGORY SCOTTreporter.nih.gov
Characterization of TRPC6 to predict and prevent chemotherapy-related heart failureNIHNational Heart, Lung, and Blood Institute2022$497,637September 22, 2022August 31, 2024NORTON, NADINEreporter.nih.gov
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)NIHNational Heart, Lung, and Blood Institute2021 to 2023$472,352January 1, 2020March 31, 2024WILSON, JESSICA ROSEreporter.nih.gov
High-throughput Screen for Discovery of Ciliary Neurotrophic Factor (CNTF) Receptor Agonists for the Treatment of Amyotrophic Lateral Sclerosis (ALS)NIHNational Institute of Neurological Disorders and Stroke2021$434,563May 1, 2020October 31, 2022ROSSOLL, WILFRIEDreporter.nih.gov
Glycogen promotes protein aggregation in ALS and FTDNIHNational Institute of Neurological Disorders and Stroke2022$430,375April 15, 2022March 31, 2025ZHANG, YONGJIEreporter.nih.gov
GLIOMA INTERACTION WITH THE NEUROGENIC NICHE THROUGH EXTRACELLULAR VESICLESNIHNational Institute of Neurological Disorders and Stroke2024$430,375September 1, 2024August 31, 2026GUERRERO-CAZARES, HUGOreporter.nih.gov
NUP50 as a modifier and risk factor for TDP-43 pathology in FTD/ALSNIHNational Institute on Aging2023$430,267September 30, 2023September 29, 2025ROSSOLL, WILFRIEDreporter.nih.gov
Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistanceNIHNational Cancer Institute2024$402,401July 8, 2024June 30, 2026SCHIAPPARELLI, PAULA Vreporter.nih.gov
Deiminated molecules as markers for developing pancreatic cancer - A1NIHNational Cancer Institute2024 to 2025$402,400December 15, 2023November 30, 2026STORZ, PETERreporter.nih.gov
Approaches and Outcomes of Shared Decision-making and Patient Centered Care Delivery in Barrett's EsophagusNIHNational Institute of Diabetes and Digestive and Kidney Diseases2024 to 2025$399,159September 1, 2022May 31, 2027ELURI, SWATHIreporter.nih.gov
Deep learning for opportunistic screening for osteoporosis and osteopenia from radiographsNIHNational Institute of Biomedical Imaging and Bioengineering2024$391,669March 13, 2024December 5, 2024SEBRO, RONNIEreporter.nih.gov
Restoring immune-vascular axis integrity to alleviate acute lung injury in sepsisNIHNational Heart, Lung, and Blood Institute2022$391,250September 1, 2022August 31, 2024PAL, KRISHNENDUreporter.nih.gov
Sex differences in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersNIHNational Institute of Arthritis and Musculoskeletal and Skin Diseases2025$379,148September 17, 2025August 31, 2027FAIRWEATHER, DELISAreporter.nih.gov
Endoscopic-mediated hydrodynamic gene therapy for hemophilia B through the biliary systemNIHNational Heart, Lung, and Blood Institute2021 to 2022$377,511September 1, 2021June 30, 2024KUMBHARI, VIVEKreporter.nih.gov
Metabolic interactions between tumor cells and the immune system in GBM: A potential Achilles heel of GBM for novel therapeuticsNIHNational Institute of Neurological Disorders and Stroke2025$366,265December 4, 2024July 31, 2027DELEYROLLE, LOIC PIERREreporter.nih.gov
Antibiotic Allergy: Phenotypes, Endotypes, and MechanismsNIHNational Institute of Allergy and Infectious Diseases2025$351,394July 3, 2025June 30, 2027BLUMENTHAL, KIMBERLY G.reporter.nih.gov
Role of the Syx-RhoA signaling axis in glioma cell growth and disseminationNIHNational Institute of Neurological Disorders and Stroke2022$342,835May 15, 2018December 31, 2023ANASTASIADIS, PANAGIOTIS Z.reporter.nih.gov
Factors Influencing Access and Utilization of Genetic Prenatal Care Services Among Women from Underserved PopulationsNIHNational Human Genome Research Institute2021 to 2022$290,444March 5, 2018July 30, 2023ALLYSE, MEGAN A.reporter.nih.gov
Vitamin D binding protein (DBP) in innate immune cell response in viral myocarditisNIHNational Institute of Allergy and Infectious Diseases2021 to 2022$253,675June 22, 2021August 5, 2022BRUNO, KATELYN ANNreporter.nih.gov
Renal repair effects of senolytic preconditioned mesenchymal stromal cells in diabetic kidney diseaseNIHNational Institute of Diabetes and Digestive and Kidney Diseases2021$237,908June 25, 2020March 31, 2023HICKSON, LATONYA Jreporter.nih.gov
Implementation of automated staining in conjunction with spatial analysesNIHOffice of the Director, National Institutes of Health2023$235,697July 1, 2023June 30, 2024THOMPSON, E. AUBREYreporter.nih.gov
Epigenetic Regulation of T Cell Metabolism and Immune Functions by Sirt6NIHNational Cancer Institute2025$219,491January 1, 2025December 31, 2026HAMAIDI, IMENEreporter.nih.gov
ECT2 Isoform Switch in Pancreatic Cancer.NIHNational Cancer Institute2025$219,491December 1, 2024November 30, 2026JUSTILIEN, VERLINEreporter.nih.gov
Optimizing CAR T therapy via metabolic engineering for thetreatment of GBMNIHNational Cancer Institute2024$203,187July 5, 2023August 31, 2025DELEYROLLE, LOIC PIERREreporter.nih.gov
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)NIHNational Institute of Allergy and Infectious Diseases2021$195,625February 1, 2020January 31, 2023FAIRWEATHER, DELISAreporter.nih.gov
Florida Cancer ReTOOL Program for Underrepresented Minority StudentsNIHNational Cancer Institute2022$164,803June 11, 2021May 31, 2023ODEDINA, FOLAKEMI Treporter.nih.gov
Mesenchymal stem cell senescence in diabetic nephropathy (K23 COVID Admin Supplement)NIHNational Institute of Diabetes and Digestive and Kidney Diseases2021$163,935May 19, 2020December 31, 2022HICKSON, LATONYA Jreporter.nih.gov
Machine learning to predict incident MCI using standard clinical measuresNIHNational Institute on Aging2021$157,708March 1, 2021February 29, 2024CHANDLER, MELANIE Jreporter.nih.gov
PKD1 signaling in the initiation of pancreatic cancerNIHNational Cancer Institute2021$145,771December 1, 2015November 30, 2021STORZ, PETERreporter.nih.gov
Neuropathological changes underlying clinical heterogeneity in Alzheimer diseNIHNational Institute on Aging2025$140,341August 15, 2016May 31, 2026GRINBERG, LEA TENENHOLZreporter.nih.gov
Sex differences in exercise-induced mitochondrial function during viral myocarditisNIHNational Institute of Allergy and Infectious Diseases2021$113,606August 1, 2020July 31, 2023FAIRWEATHER, DELISAreporter.nih.gov
The Role of TMEM106B in FTLD-TDP PathogenesisNIHNational Institute on Aging2024 to 2025$98,912December 6, 2023June 5, 2027MARKS, JORDAN DAVIDreporter.nih.gov
Neural stem cells proteomic contribution to glioblastoma malignancyNIHNational Institute of Neurological Disorders and Stroke2021 to 2022$84,809August 2, 2021April 13, 2023NORTON-RAMOS, EMILY SHANNONreporter.nih.gov
Querying the Interactome of Alpha-Synuclein During Pathological ProcessesNIHNational Institute of Neurological Disorders and Stroke2025$49,538August 27, 2025August 26, 2027FERNANDES, ANALIESEreporter.nih.gov
Harnessing the mesenchymal stromal cell secretome to target alpha-synuclein associated dysfunction in Parkinson's disease and related disorders.NIHNational Institute on Aging2021$46,036September 1, 2020August 31, 2023BURGESS, JEREMY DANIELreporter.nih.gov
Science of Community Outreach and Engagement (SoCOE) ConferenceNIHNational Cancer Institute2024 to 2025$20,000May 1, 2024June 30, 2029ODEDINA, FOLAKEMI Treporter.nih.gov
Inaugural Conference on Implementation Science for Cancer Control in Africa (ISC2-Africa)NIHNational Cancer Institute2021$15,000September 8, 2021August 31, 2022ODEDINA, FOLAKEMI Treporter.nih.gov

Funding by fiscal year

Fiscal yearNIH awardsNIH amountNSF awardsNSF amount
202558$57,938,0270$0
202460$58,643,4820$0
202356$57,093,3130$0
202258$51,870,1450$0
202160$50,144,8770$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunityNumberAgencyListingClosesAward ceilingWhy it matches
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)PA-24-254NIHJuly 12, 2027Not listedNotice number printed on 3 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)PAR-25-095NIH93.866November 6, 2026$350,000Same assistance listing 93.866 as 42 awards here
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)RFA-AG-27-010NIH93.866November 10, 2026Not listedSame assistance listing 93.866 as 42 awards here
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)PAR-25-096NIH93.866November 17, 2026$200,000Same assistance listing 93.866 as 42 awards here
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)RFA-AT-25-003NIH93.866November 23, 2026$375,000Same assistance listing 93.866 as 42 awards here
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)PA-23-317NIH93.866November 24, 2026Not listedSame assistance listing 93.866 as 42 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Required)PAR-24-295NIH93.866December 3, 2026Not listedSame assistance listing 93.866 as 42 awards here
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)PAR-24-296NIH93.866December 3, 2026Not listedSame assistance listing 93.866 as 42 awards here
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)RFA-OD-24-011NIH93.866December 4, 2026Not listedSame assistance listing 93.866 as 42 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)PAR-27-039NIH93.866January 5, 2027Not listedSame assistance listing 93.866 as 42 awards here
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)PAR-27-040NIH93.866January 5, 2027Not listedSame assistance listing 93.866 as 42 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)PAR-24-214NIH93.866January 7, 2027$375,000Same assistance listing 93.866 as 42 awards here
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)PAR-25-378NIH93.866January 7, 2027Not listedSame assistance listing 93.866 as 42 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)PAR-25-379NIH93.866January 7, 2027Not listedSame assistance listing 93.866 as 42 awards here
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)RFA-NS-25-023NIH93.866January 15, 2027$350,000Same assistance listing 93.866 as 42 awards here
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious DiseasesRFA-AI-28-014NIH93.866January 22, 2027Not listedSame assistance listing 93.866 as 42 awards here
HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)RFA-DA-28-011NIH93.866January 26, 2027Not listedSame assistance listing 93.866 as 42 awards here
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed)RFA-DA-28-012NIH93.866January 26, 2027Not listedSame assistance listing 93.866 as 42 awards here
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)PAR-24-268NIH93.866January 27, 2027$500,000Same assistance listing 93.866 as 42 awards here
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)RFA-NS-24-031NIH93.866January 28, 2027$750,000Same assistance listing 93.866 as 42 awards here

Topics of its NIH awards

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.